Lugong, Armando, SR.. M.

HRN: 22-91-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
CEFTRIAXONE 1G (VIAL)
04/18/2023
04/24/2023
IV
2g
OD
CAP-MR
Waiting Final Action 
04/18/2023
AZITHROMYCIN 500MG TABLET (TAB)
04/18/2023
04/22/2023
PO
500mg
OD
CAP-MR
Waiting Final Action 
04/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/18/2023
04/24/2023
IV
500mg
Q8
Intra-abdominal Infection
Waiting Final Action 
04/22/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/22/2023
04/29/2023
IV INFUSION
4.5gms
Q6H
CAP MR; Presumptive PTB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: